AB

Aspect Biosystems

Verified Job Source

Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.

Vancouver, British Columbia

Biotechnology Research
51–200 people

About

Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.

Open positions

In Vivo Technician

On-site · Vancouver

The In Vivo Technician will support preclinical studies by performing animal handling, dosing, and health monitoring while maintaining accurate experimental records. They are also responsible for facility maintenance, biosecurity, and the collection of tissue samples for research analysis.

Senior Process Engineer (12 Month Contract)

On-site · Vancouver

The Senior Process Engineer will lead the design, implementation, and characterization of complex fluidic systems and automated cell processing workflows for bioprinted tissue therapeutics. They will also support technology transfer to manufacturing, perform process risk assessments, and ensure technical integration of the cell therapy process into the final device platform.

Associate Process Engineer (12 month contract)

On-site · Vancouver

The Associate Process Engineer will support the development of aseptic manufacturing workflows for bioprinted tissue therapeutics, including fluidic system design and bioreactor scaling. They will also collaborate with cross-functional teams to integrate processes into device platforms and support technology transfer to manufacturing.